Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung

NCT02483403
terminated

A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease

NCT02734368
terminatednot_applicable

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

NCT00846573
completednot_applicable

Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI

NCT00846287

Clinical Trials (4)

Showing 4 of 4 trials
NCT02483403Not Applicable

Longitudinal 3He Magnetic Resonance Imaging of Healthy Lung

Completed
NCT02734368

A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease

Terminated
NCT00846573Not Applicable

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

Terminated
NCT00846287Not Applicable

Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4